← Leaderboards
Patricia A Marks
University Of Arkansas Med Scis Ltl Rock
$346,183
Attributed
$346,183
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $118.8K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$346,183 · 4
By mechanism
P20$346,183 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Arkansas Med Scis Ltl Rock
Same institution · by research overlap
- Robert Joseph Shmookler-Reis$3,488,849
- Tammy L Kielian$23,568,259
- Barry D Gehm$666,156
- Brian T Greuel$501,503
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionGastrinsCytokineBinding (Molecular Function)BoxingCckbr GeneBlotting, WesternCellsC-Myc GenesColorectal CancerComplexComputer Retrieval Of Information On Scientific Projects DatabaseConsensusDna, ComplementaryDna BindingCell CountE-Box ElementsEgf GeneElectrophoretic Mobility Shift AssayElectroporationExonsExpression VectorFundingBiotin
Grant awards (5)
PROTO-ONCOGENE AND CYTOKINE REGULATION OF THE HUMAN GASTRIN PROMOTER$118,813
P20 · FY2008 · RR · contact PI
PROTO-ONCOGENE AND CYTOKINE REGULATION OF THE HUMAN GASTRIN PROMOTER$110,935
P20 · FY2007 · RR · contact PI
PROTO-ONCOGENE AND CYTOKINE REGULATION OF THE HUMAN GASTRIN PROMOTER$99,933
P20 · FY2006 · RR · contact PI
PROTO-ONCOGENE AND CYTOKINE REGULATION OF THE HUMAN GASTRIN PROMOTER$14,721
P20 · FY2005 · RR
PROTO-ONCOGENE /CYTOKINE REGULATION OF HUMAN GASTRIN PRO$1,781
P20 · FY2004 · RR